IPNews® – Pfizer Inc. and Northwestern University filed a lawsuit on Friday in an attempt to prevent a generic-drug manufacturer from producing a form of the patented drug Lyrica.
The company and the university have actively fought to protect the patent for the drug, which brought in more than $3.7 billion in revenues in 2011. Wockhardt Ltd. claims that the patent should be invalid due to obviousness and is attempting to obtain permission to manufacture and distribute a generic form of the drug in America.
To continue reading, click: Pfizer Claims Generic-Drug Makers Infringe Lyrica Patent